Eversept Partners’s Acceleron Pharma XLRN Stock Holding History

Eversept Partners’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-349,494	Closed	-$60.1M	–	132
2021 Q3	$60.1M	Buy	349,494 +14,449	+4%	+$1.89M	4.16%	5
2021 Q2	$42M	Buy	335,045 +93,064	+38%	+$11.7M	2.8%	11
2021 Q1	$32.8M	Buy	+241,981	New	+$31.3M	2.47%	13
2020 Q2	–	Sell	-42,305	Closed	-$3.8M	–	81
2020 Q1	$3.8M	Buy	+42,305	New	+$3.29M	0.95%	25

Eversept Partners's XLRN Position: Q4 2021 in Review

Eversept Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 349,494 shares — an estimated $60.1M sold.

Eversept Partners first reported a position in XLRN in Q1 2020 and held it in 4 quarters. The position peaked at $60.1M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Eversept Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Eversept Partners sold 349,494 Acceleron Pharma shares in Q4 2021, an estimated $60.1M.
Eversept Partners first reported a position in Acceleron Pharma in Q1 2020 and held it in 4 quarters.
Eversept Partners's Acceleron Pharma position peaked at $60.1M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Eversept Partners's 13F filing for Q4 2021, filed 14 Feb 2022.